What is Ekso Bionics Holdings Inc Annual Revenue?

Ekso Bionics Holdings Inc Annual Revenue fell 1.94%, in the last year to $17.92 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Ekso Bionics Holdings Inc Annual Net Profit?

Ekso Bionics Holdings Inc Annual Net Profit rose 25.45% in the last year to $11.33 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Ekso Bionics Holdings Inc Price to Earning Ratio?

Ekso Bionics Holdings Inc Price to Earning Ratio is -1, which is negative.

What is Ekso Bionics Holdings Inc Stock Price?

Ekso Bionics Holdings Inc Stock Price fell 69.7% and underperformed its sector by 77.41% in the past year.

What is Ekso Bionics Holdings Inc Quarterly Revenue?

Ekso Bionics Holdings Inc Quarterly Revenue rose 5.01% YoY to $5.09 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Ekso Bionics Holdings Inc Quarterly Net profit?

Ekso Bionics Holdings Inc Quarterly Net profit fell 6.19% YoY to $3.41 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

What is Ekso Bionics Holdings Inc Debt to Equity Ratio?

Ekso Bionics Holdings Inc Debt to Equity Ratio of 0.47 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Ekso Bionics Holdings Inc Return on Equity(ROE)?

Ekso Bionics Holdings Inc Return on Equity(ROE) for the last financial year was -89.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Ekso Bionics Holdings Inc Mutual Fund Holding?

Ekso Bionics Holdings Inc Mutual Fund Holding decreased by 1.71% in the last quarter to 6.04.

What is Ekso Bionics Holdings Inc Promoter Share Holding?

Ekso Bionics Holdings Inc Promoter Share Holding stayed the same in the most recent quarter at 1.95%.

What is Ekso Bionics Holdings Inc Interest Coverage Ratio?

Ekso Bionics Holdings Inc Interest Coverage Ratio is -41.12, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Ekso Bionics Holdings Inc Institutional Holding?

Ekso Bionics Holdings Inc Institutional Holding decreased by 0.01% in the last quarter to 17.5.

How is the Ekso Bionics Holdings Inc today?

The Ekso Bionics Holdings Inc today is trading in the down by -2.44% at 0.40.

How has Ekso Bionics Holdings Inc performed historically?

The Ekso Bionics Holdings Inc is currently trading down -2.44% on an intraday basis in the past week the index rose 5.26%. The index has been down -36.51% in the past quarter and fell -69.70% in the past year. You can view this in the overview section.

Ekso Bionics Holdings Inc XNAS: EKSO

Ekso Bionics Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Ekso Bionics Holdings Inc: Is Infosys Ltd. worth buying?
Item: Ekso Bionics Holdings Inc
Rating: 1.34091675
Author: Trendlyne DVM scores

Download real time

0.40 -0.01 (-2.44%)

73.86% Fall from 52W High

100.4K XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Ekso Bionics Holdings Inc is on 29 Apr 2025 for the purpose of Ekso Bionics Holdings Inc First Quarter Earnings Results for 2025 See details

Ekso Bionics Holdings Inc Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	11.3
PE TTM Negative PE TTM Unavailable in chosen country	-1
Price to Book Below industry Median Unavailable in chosen country	0.9
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	17.5
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	5
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-1.9
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-6.2
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	25.5
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-43.8
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-58.4
Piotroski Score Below industry Median Unavailable in chosen country	3
Rel Perf vs Sector quarter% Unavailable in chosen country	-27.7
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-89.5
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-40.8

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

26.7 / 100

Technically Bearish

27.0 / 100

1Yr Price target upside is 1150%

2 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Ekso Bionics Holdings Inc Stock Price Analysis

Day Price Range -2.4% 1 Day return Unavailable in chosen country	0.4 (LTP) 0.40.4 LowHigh
Week Price Range 5.3% 1 Week return Unavailable in chosen country	0.4 (LTP) 0.40.4 LowHigh
Month Price Range -20.0% 1 Month return Unavailable in chosen country	0.4 (LTP) 0.30.5 LowHigh
52 Week Price Range -69.7% 1 Year return Unavailable in chosen country	0.4 (LTP) 0.31.5 LowHigh

View full Share Price History

Ekso Bionics Holdings Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Ekso Bionics Holdings Inc's Revenue was higher than average estimate 2 times in past 2 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.6

Avg. Estimate

-0.3

Low Estimate

-0.4

High Estimate

-0.2

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 42.9% in FY25

Consensus Recommendation

2 ANALYST Recommendations

BUY

The consensus recommendation from 2 analysts for Ekso Bionics Holdings Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Ekso Bionics Holdings Inc Stock Analysis

Ekso Bionics Holdings Inc stock analysis with key metrics, changes, and trends.

Ekso Bionics Holdings Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$17.92 M	1.94%	negative	Annual Revenue fell 1.94%, in the last year to $17.92 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$11.33 M	25.45%	positive	Annual Net Profit rose 25.45% in the last year to $11.33 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	-1	-	negative	Price to Earning Ratio is -1, which is negative.
Stock Price	$0.40	-69.7%	negative	Stock Price fell 69.7% and underperformed its sector by 77.41% in the past year.
Quarterly Revenue	$5.09 M	5.01%	positive	Quarterly Revenue rose 5.01% YoY to $5.09 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$3.41 M	6.19%	negative	Quarterly Net profit fell 6.19% YoY to $3.41 M. Its sector's average net profit growth YoY for the quarter was 32.9%.
Debt to Equity Ratio	0.47	-	positive	Debt to Equity Ratio of 0.47 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-89.52 %	-89.52%	negative	Return on Equity(ROE) for the last financial year was -89.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	6.04 %	-1.71%	negative	Mutual Fund Holding decreased by 1.71% in the last quarter to 6.04.
Promoter Share Holding	1.95 %	0%	neutral	Promoter Share Holding stayed the same in the most recent quarter at 1.95%.
Interest Coverage Ratio	-41.12	-	negative	Interest Coverage Ratio is -41.12, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	17.50 %	-0.01%	negative	Institutional Holding decreased by 0.01% in the last quarter to 17.5.

VIEW LESS

Loading data..

Ekso Bionics Holdings Inc - Company Profile

What does Ekso Bionics Holdings Inc do?

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

2024

Gross Remuneration

Year

Ekso Bionics Holdings Inc Live Share Price Today, Share Analysis and Chart

73.86% Fall from 52W High

Ekso Bionics Holdings Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

ROE Annual %

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

RoA Annual %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Ekso Bionics Holdings Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Ekso Bionics Holdings Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Ekso Bionics Holdings Inc's Revenue was higher than average estimate 2 times in past 2 years

EPS forecast

EPS is expected to grow by 42.9% in FY25

Consensus Recommendation

The consensus recommendation from 2 analysts for Ekso Bionics Holdings Inc is BUY

Ekso Bionics Holdings Inc Stock Analysis

Ekso Bionics Holdings Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 1.94%, in the last year to $17.92 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit rose 25.45% in the last year to $11.33 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is -1, which is negative.

Stock Price fell 69.7% and underperformed its sector by 77.41% in the past year.

Quarterly Revenue rose 5.01% YoY to $5.09 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 6.19% YoY to $3.41 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio of 0.47 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -89.52%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.71% in the last quarter to 6.04.

Promoter Share Holding stayed the same in the most recent quarter at 1.95%.

Interest Coverage Ratio is -41.12, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding decreased by 0.01% in the last quarter to 17.5.

Ekso Bionics Holdings Inc - Company Profile

What does Ekso Bionics Holdings Inc do?

Ekso Bionics Holdings Inc Management structure

Mr. Scott G. Davis

Director and Chief Executive Officer

Mr. Jerome Wong

Principal Accounting Officer, Chief Financial Officer and Corporate Secretary

Mr. Jason C. Jones

Chief Operating Officer

Ekso Bionics Holdings Inc Board of directors

Ms. Mary Ann Cloyd

Lead Independent Director

Dr. Corinna E. Lathan, PhD

Independent Director

Dr. Charles Li, PhD

Independent Director

Ms. Deborah Lafer Scher

Independent Director

Ms. Rhonda A. Wallen